Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Pedro Bretcha Boix"'
Autor:
Alba Fernández-Candela, Pedro Bretcha-Boix, Juan Carlos Ruíz Ramírez, Alejandro Paz, Paula Munoz, Miguel A. Ortega, Melchor Álvarez-Mon, José Farré-Alegre
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 1, p 297 (2024)
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have demonstrated their impact on disease-free survival (DFS) and overall survival (OS) of patients with peritoneal metastases (PM). However, prior literature lacks evi
Externí odkaz:
https://doaj.org/article/99ee09f4f1864e7d8e867590e2c81c01
Publikováno v:
Cancers, Vol 14, Iss 17, p 4091 (2022)
Surgery is the key treatment in retroperitoneal sarcoma (RPS), as completeness of resection is the most important prognostic factor related to treatment. Compartmental surgery/frontline extended approach is based on soft-tissue sarcoma surgical princ
Externí odkaz:
https://doaj.org/article/a90763f77e3a46828363f0fc4e192b3f
Autor:
Alejandro Paz Yáñez, Rodolfo Martín Diaz, Paula Muñoz Muñoz, Jose Rolando Ortega Ramírez, Pedro Bretcha Boix, Antonio Brugarolas Masllorens
Publikováno v:
European Journal of Surgical Oncology. 49:e94
Autor:
Olivier Glehen, Armando Sardi, Maurie Markman, Arancha Prada-Villaverde, Martin D. Goodman, A. Gomez-Portilla, Kiran K. Turaga, Evgenia Halkia, Richard Trout, George I. Salti, Guillermo Flores-Ayala, Marcello Deraco, Santiago González-Moreno, Juan Torres-Melero, Richard Berri, Pedro Bretcha-Boix, Shigeki Kusamura, Joerg O.W. Pelz, Mecker G. Möller, Guillaume Passot, Maheswari Senthil, Jesus Esquivel, John Spiliotis, Dario Baratti, Marc Pocard, Terence Chua, Joel M. Baumgartner, Andrew M. Lowy
Publikováno v:
Journal of Surgical Oncology. 110:779-785
Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) are gaining acceptance as treatment for selected patients with colorectal cancer with peritoneal carcinomatosis (CRCPC). Tremendous variations exist in the HIPEC d
Autor:
Antonio Brugarolas Masllorens, Manuel Sureda, Juan José Pérez Ruixo, Pedro Bretcha-Boix, Carlos Dussan, José Farré-Alegre
Publikováno v:
Clinical and Translational Oncology. 12:437-442
Peritoneal carcinomatosis is a relatively frequent situation in the natural history of colorectal cancer and is associated with a dismal prognosis. Promising results have been shown after radical cytoreduction followed by intraperitoneal chemohyperth
Autor:
Jose Farré Alegre, Carlos Alberto Dussán Luberth, Maritza Duarte Llanos, Pedro Bretcha Boix, Rodolfo Diaz Blanco
Publikováno v:
Progresos de Obstetricia y Ginecología. 56:525-527
Resumen La evisceracion intestinal a traves de la vagina es una complicacion poco frecuente, pero que representa una urgencia. Tanto su patogenia como su prevencion estan discutidas. El tiempo medio de aparicion es de 128 dias. Presentamos el caso de
Autor:
Pedro Bretcha-Boix, José Esteban Peris, Belén Valenzuela, Carlos Pérez-Ruixo, Vanesa Escudero-Ortiz, José Farré-Alegre, Juan Jose Perez-Ruixo
Publikováno v:
The AAPS journal. 18(1)
The aim of the study was to characterize the platelet count (PLT) dynamics in peritoneal carcinomatosis patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal oxaliplatin (HIO). Data from patients treated with CRS alone (N
Autor:
Arancha, Prada-Villaverde, Jesus, Esquivel, Andrew M, Lowy, Maurie, Markman, Terence, Chua, Joerg, Pelz, Dario, Baratti, Joel M, Baumgartner, Richard, Berri, Pedro, Bretcha-Boix, Marcello, Deraco, Guillermo, Flores-Ayala, Olivier, Glehen, Alberto, Gomez-Portilla, Santiago, González-Moreno, Martin, Goodman, Evgenia, Halkia, Shigeki, Kusamura, Mecker, Moller, Guillaume, Passot, Marc, Pocard, George, Salti, Armando, Sardi, Maheswari, Senthil, John, Spiliotis, Juan, Torres-Melero, Kiran, Turaga, Richard, Trout
Publikováno v:
Journal of surgical oncology. 110(7)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) are gaining acceptance as treatment for selected patients with colorectal cancer with peritoneal carcinomatosis (CRCPC). Tremendous variations exist in the HIPEC delivery.The
Autor:
Carlos Pérez-Ruixo, José E. Peris, Belén Valenzuela, Vanesa Escudero-Ortiz, Pedro Bretcha-Boix, José Farré-Alegre, Juan Jose Perez-Ruixo
Publikováno v:
Cancer chemotherapy and pharmacology. 73(5)
To determine the rate and extent of hyperthermic intraperitoneal oxaliplatin (HIO) absorption in peritoneal carcinomatosis patients treated with cytoreductive surgery (CRS) and the effect of the isotonic carrier solution on HIO absorption parameters.
Autor:
Pedro Bretcha-Boix, Miquel Mateu-Navarro, Ramón Rami-Porta, Carlos Hoyuela-Alonso, Constancio Marco-Molina
Publikováno v:
Lung Cancer. 27:101-105
Surgical treatment of adrenal metastasis from non-small cell lung cancer is controversial. Classically this group of patients has been considered incurable, therefore excision of the primary cancer and the adrenal gland has been avoided. However, rec